Molecular mechanisms of cancer cell invasion and plasticity

Area of Science:

• Cell biology
• Biochemistry
• Oncology

Background:

• Cancer cell migration relies on integrins, cytoskeleton dynamics, and proteolysis to breach tissue barriers.
• Three-dimensional (3D) models like collagen lattices and dermal explants advance understanding of tumor cell migration and matrix remodeling.
• Mesenchymal HT-1080 fibrosarcoma cells exhibit integrin-dependent migration and extracellular matrix proteolysis.

Purpose of the Study:

• To investigate the plasticity of cancer cell migration programs in response to therapeutic interventions.
• To explore alternative migration mechanisms adopted by cancer cells upon interference with integrin and protease functions.
• To understand the implications of these adaptive responses for tumor invasion and dissemination.

Main Methods:

• Utilized three-dimensional (3D) dermis equivalents, including 3D collagen lattices and dermal explant cultures.
• Employed mesenchymal HT-1080 fibrosarcoma cells as a model system for studying cancer cell migration.
• Interfered with integrin and protease function to observe changes in cell migration behavior.

Main Results:

• Cancer cells demonstrated an ability to switch migration programs when integrin or protease function was inhibited.
• Interventions targeting integrins or proteases induced mesenchymal-amoeboid and collective-amoeboid transitions.
• These transitions facilitated sustained dissemination of single cancer cells, highlighting migratory plasticity.

Conclusions:

• Cancer cell migration exhibits significant plasticity, allowing cells to adopt alternative 'escape' strategies.
• Pharmacotherapeutic interventions targeting specific pathways can inadvertently promote cancer cell dissemination through alternative mechanisms.
• Understanding these adaptive responses is crucial for developing effective anti-cancer therapies that prevent tumor invasion and metastasis.